Vaccine re-challenge
Showing 26 - 50 of >10,000
Dengue Trial in Baltimore (Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose, Dengue 4 Live Virus Human Challenge
Recruiting
- Dengue
- Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Mar 1, 2022
Malaria Trial in Seattle (PfSPZ Vaccine, PfSPZ Challenge (7G8) for CHMI, Normal Saline)
Completed
- Malaria
- PfSPZ Vaccine
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Jul 15, 2022
Immunising Mums Against Pertussis 3
Completed
- Whooping Cough
- +2 more
- Pre-school booster vaccine
-
Gloucester, United Kingdom
- +2 more
Apr 8, 2022
Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)
Recruiting
- Shigella
- SF2a-TT15 Shigella Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022
Respiratory Syncytial Virus Infections Trial in London (RSVPreF, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- RSVPreF
- Placebo
-
London, United KingdomGolam Kabir
Sep 1, 2021
BCG Vaccination on Infectious and Immune Mediated Diseases
Enrolling by invitation
- BCG Vaccination Reaction
- +3 more
- BCG
- Placebo vaccine
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Oct 25, 2022
Shigella Trial in Baltimore (CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a)
Terminated
- Shigella
- CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
-
Baltimore, Maryland
- +1 more
Apr 27, 2021
Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)
Recruiting
- Vaccine Response Impaired
- BCG vaccine
- +3 more
-
Adelaide, South Australia, AustraliaSouth Australian Health and Medical Research Institute
Nov 17, 2023
Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)
Recruiting
- Immune Response
- Keyhole-Limpet Hemocyanin
- +3 more
-
Oxford, United KingdomNIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023
Salmonella Typhi Infection Trial in Oxford (Salmonella Typhi (S. Typhi))
Unknown status
- Salmonella Typhi Infection
- Salmonella Typhi (S. Typhi)
-
Oxford, Oxfordshire, United KingdomOxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Dec 9, 2021
Malaria Trial in Bamako (biological, drug, other)
Completed
- Malaria
- PfSPZ Vaccine
- +5 more
-
Bamako, MaliUniversity of Bamako (USTTB/MRTC)
Apr 19, 2021
COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)
Recruiting
- COVID-19
- Corona Virus Infection
- Pfizer-BioNTech mRNA COVID-19 vaccine
- Moderna mRNA COVID-19 vaccine
-
Ann Arbor, MichiganUniversity of Michigan
Apr 23, 2022
Shigellosis Trial in Baltimore (Flexyn2a, Placebo)
Completed
- Shigellosis
- Flexyn2a
- Placebo
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health, CIR
Jan 7, 2021
Enterotoxigenic Escherichia Coli Infection, Diarrhea Trial in Baltimore (VLA1701, Placebo, Challenge Strain)
Completed
- Enterotoxigenic Escherichia Coli Infection
- Diarrhea
- VLA1701
- +2 more
-
Baltimore, MarylandDepartment of International Health Johns Hopkins University
Mar 29, 2021
Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)
Not yet recruiting
- Infectious Disease
- +3 more
- Stamaril
- +2 more
- (no location specified)
Oct 3, 2022
Volunteer Screening for Vaccine and Antivirals Clinical Trials
Completed
- Normal Physiology
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 30, 2021
Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)
Not yet recruiting
- Shigellosis
- Bacillary Dysentery
- 2.5 μg InvaplexAR-Detox
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Jul 26, 2023
Influenza Trial in United States (Influenza A/Bethesda/MM2/H1N1 Challenge)
Completed
- Influenza
- Influenza A/Bethesda/MM2/H1N1 Challenge
-
Baltimore, Maryland
- +3 more
Apr 1, 2021
Malaria,Falciparum, Plasmodium Falciparum, Plasmodium Berghei Trial in Nijmegen, Rotterdam (Pb(PfCS@UIS4)-infected mosquitoes,
Completed
- Malaria,Falciparum
- +3 more
- Pb(PfCS@UIS4)-infected mosquitoes
- Challenge infection P. falciparum
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 23, 2022
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Terminated
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore Center for Vaccine Development
Apr 27, 2021
MALARIA, FEVER, Sweating Fever Trial in Cali (413ABM, 414WRR, 418JAL)
Completed
- MALARIA
- +4 more
- 413ABM
- +2 more
-
Cali, Valle, ColombiaMalaria Vaccine and Drug Development Center
Feb 25, 2021
Human Immunodeficiency Virus, Herpes Simplex Type II, Chlamydia Trial in Umlazi (Mentoring Adolescent Mothers at School (MAMAS))
Completed
- Human Immunodeficiency Virus
- +4 more
- Mentoring Adolescent Mothers at School (MAMAS)
-
Umlazi, South AfricaPhilasende Clinic
Sep 20, 2021
Melanoma Trial in Australia, New Zealand, United Kingdom (NY-ESO-1 ISCOMATRIX®, ISCOMATRIX® adjuvant)
Completed
- Melanoma
- NY-ESO-1 ISCOMATRIX®
- ISCOMATRIX® adjuvant
-
Camperdown, New South Wales, Australia
- +14 more
Oct 3, 2022